Effect of misonidazole dose on survival in patients with stage IIIB-IVA squamous cell carcinoma of the uterine cervix: An RTOG randomized trial
- 31 July 1986
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 12 (7), 1101-1103
- https://doi.org/10.1016/0360-3016(86)90235-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The Medical Research Council trial of misonidazole in carcinoma of the uterine cervixThe British Journal of Radiology, 1984
- Clinical perspectives for the use of new hypoxic cell sensitizersInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Radiation therapy oncology group clinical trials with misonidazoleCancer, 1981
- Misonidazole in fractionated radiotherapy: are many small fractions best?The British Journal of Radiology, 1980
- Hypoxic Sensitizers — Implications for Radiation TherapyNew England Journal of Medicine, 1979
- Carcinoma of the cervix.Present status and futureCancer, 1977
- Analysis of Sites and Causes of Failures of Irradiation in Invasive Squamous Cell Carcinoma of the Intact Uterine CervixRadiology, 1975
- Critical points of failure in the therapy of cancer of the cervix: A reappraisalAmerican Journal of Obstetrics and Gynecology, 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958